Ferryx
Bristol, GB · Founded 2019 · 6 employees on LinkedIn · 1 known investors
Find your way into Ferryx
Ferryx develops next-generation probiotics aimed at improving gut health for people experiencing active flare-ups of gut conditions. A 2019 spin-out from the University of Bristol, the company works to bring these probiotics into commercial production.
Founders & leadership
Ferryx was founded in 2019 by Jenny Bailey Cooper.
JB
Jenny Bailey CooperinFounderA scientist with over 20 years of research experience in gut health and intestinal inflammation, holding a PhD in gastrointestinal immunology from the University of Bristol. In 2019 she co-founded Ferryx, a University of Bristol spin-out, where she serves as CEO and has led the development of Ferrocalm, a probiotic built around the bacterial strain Streptococcus thermophilus FX856, through funding, clinical trials, regulatory strategy, and its 2022 launch.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseedSep 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- FERRYX LIMITED
- Company number
- 12193693
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 6 Sept 2019
- Registered office
- Future Space Uwe North Gate, Filton Road, Stoke Gifford, Bristol, BS34 8RB
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 30 Sept 2025 · next due 30 Jun 2027
- Confirmation statement
- last made up to 18 Dec 2025 · next due 1 Jan 2027
Current officers · 4
- Jennifer Ruth Bailey — director, appointed 18 Nov 2019
- Tristan Alexander Cogan — director, appointed 18 Nov 2019
- Le Roy Dowey — director, appointed 18 May 2022
- John Stephen Fox — director, appointed 18 Nov 2019
Source: Companies House public register · retrieved 6 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Ferryx do?
- Ferryx develops next-generation probiotics aimed at improving gut health for people experiencing active flare-ups of gut conditions. A 2019 spin-out from the University of Bristol, the company works to bring these probiotics into commercial production.
- Who founded Ferryx?
- Ferryx was founded by Jenny Bailey Cooper in 2019.
- Who are Ferryx's investors?
- Ferryx's investors include Deepbridge Capital.
- Where is Ferryx headquartered?
- Ferryx is headquartered in Bristol, GB.